OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment
Yin Li, Manling Jiang, Ling Aye, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance
Zhi Liu, Chunyu Zhang, Jiatong Xiao, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1966-1986
Open Access

Progress in understanding the regulatory mechanisms of immune checkpoint proteins PD-1 and PD-L1 expression
Xuanxuan Wu, Zengjun Zhu, Jian Zhang, et al.
Clinical & Translational Oncology (2025)
Closed Access

Construction of a circRNA-miRNA-mRNA Regulatory Network for the Immune Regulation of Lung Adenocarcinoma
Hanyi Li, Xin Jin, Wei Li, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access

MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma
Yan Chen, Xinsheng Zhu, Jue Wang, et al.
Oncogene (2024)
Closed Access | Times Cited: 2

Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas
Zigui Chen, Chao Liu, Chunyuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

FANCA promotes lung adenocarcinoma progression and is a potential target for epitope vaccine immunotherapy
Yanli Kang, Ruifang Zhong, Yuhan Gan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Uridine Phosphorylase-1 supports metastasis of mammary cancer by altering immune and extracellular matrix landscapes of the lung
Declan Whyte, Johan Vande Voorde, David Sumpton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

[Advancements in Single-cell RNA Sequencing Technology
in the Study of the Tumor Microenvironment in Lung Cancer].
Yanhong Wang, Bin Luo, Zhuo Wang, et al.
PubMed (2024) Vol. 27, Iss. 6, pp. 441-450
Closed Access

Multiomics and machine learning-based analysis of pancancer pseudouridine modifications
Jiheng Zhang, Lei Xu, Xiuwei Yan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access

CPBMF65, an inhibitor of uridine phosphorylase 1, suppresses psoriasiform dermatitis in mice: a potential therapeutic approach for psoriasis
Fanfan Zeng, Pengcheng Cai, Yanqiu Yu, et al.
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access

An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers
Eleftheria Klagkou, Dimitrios Valakos, Spyros Foutadakis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13128-13128
Open Access

YTHDF2 promotes arsenic-induced malignant phenotypes by degrading PIDD1 mRNA in human keratinocytes
Qian Zhang, Jin Man, Tianhe Zhao, et al.
Chemico-Biological Interactions (2024), pp. 111352-111352
Closed Access

Page 1

Scroll to top